Around the Net

F.D.A. Calls Ads for Cholesterol Pill Crestor 'False and Misleading'

AstraZeneca's recent full-page newspaper advertisements defending the safety of its cholesterol-lowering pill, Crestor, are "false and misleading," in part because serious concerns remain about the safety of the drug, federal drug regulators said Wednesday.

Read the whole story at The New York Times, December 23, 2004 »

Next story loading loading..